Lotus Bio Technology Development Stock Performance
| LBTD Stock | USD 0.01 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Lotus Bio are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Lotus Bio Technology Development has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Lotus Bio is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 1505.00 |
Lotus |
Lotus Bio Relative Risk vs. Return Landscape
If you would invest 1.00 in Lotus Bio Technology Development on April 26, 2025 and sell it today you would earn a total of 0.00 from holding Lotus Bio Technology Development or generate 0.0% return on investment over 90 days. Lotus Bio Technology Development is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Lotus, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Lotus Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lotus Bio's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Lotus Bio Technology Development, and traders can use it to determine the average amount a Lotus Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| LBTD |
Based on monthly moving average Lotus Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lotus Bio by adding Lotus Bio to a well-diversified portfolio.
Lotus Bio Fundamentals Growth
Lotus Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Lotus Bio, and Lotus Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Lotus Pink Sheet performance.
| Return On Asset | -4.21 | |||
| Current Valuation | 31.31 M | |||
| Shares Outstanding | 782.77 M | |||
| Price To Earning | (1.71) X | |||
| Cash And Equivalents | 1 | |||
| Total Debt | 16.68 K | |||
| Cash Flow From Operations | (17.75 K) | |||
| Total Asset | 5.46 K | |||
| Retained Earnings | (931 K) | |||
| Current Liabilities | 68 K | |||
About Lotus Bio Performance
By analyzing Lotus Bio's fundamental ratios, stakeholders can gain valuable insights into Lotus Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Lotus Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Lotus Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Lotus Bio-Technology Development Corp., a bio-technology development company, focuses on refining organic materials, and production of natural consumer related products in China. Lotus Bio-Technology Development Corp. was founded in 2011 and is based in Cave Creek, Arizona. Lotus Bio-Technology is traded on OTC Exchange in the United States.Things to note about Lotus Bio Technology performance evaluation
Checking the ongoing alerts about Lotus Bio for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Lotus Bio Technology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Lotus Bio Technology generated a negative expected return over the last 90 days | |
| Lotus Bio Technology has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (19.55 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Lotus Bio Technology Development currently holds about 1 in cash with (17.75 K) of positive cash flow from operations. | |
| Roughly 60.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Lotus Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Lotus Bio's stock is overvalued or undervalued compared to its peers.
- Examining Lotus Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Lotus Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Lotus Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Lotus Bio's pink sheet. These opinions can provide insight into Lotus Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Lotus Pink Sheet analysis
When running Lotus Bio's price analysis, check to measure Lotus Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Bio is operating at the current time. Most of Lotus Bio's value examination focuses on studying past and present price action to predict the probability of Lotus Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Bio's price. Additionally, you may evaluate how the addition of Lotus Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |